![S. Michael Imperiale](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
S.
Michael Imperiale is currently the Chief Safety Officer at Paradigm Biopharmaceuticals Ltd. He previously worked as the Senior Director-Medical Sciences at Nuvelo, Inc. from 2004 to 2007.
He also held positions as the Senior Director-Global Medical Affairs at BioMarin Pharmaceutical, Inc., Director-Clinical Science at InterMune, Inc., Director-Clinical Trials Development at Exelixis, Inc., and Independent Director at ScripsAmerica, Inc. Additionally, he served as the Senior Associate Director-Clinical Scientific at Boehringer Ingelheim Pharmaceuticals, Inc. from 2000 to 2004.
From 2007 to 2009, he was the Vice President-Clinical Research Operations at Talon Therapeutics, Inc. Dr. Imperiale obtained his undergraduate degree from Villanova University in 1982 and his doctorate degree from Hahnemann University in 1987.
| Empresas | Cargo | Inicio |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/06/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Director Técnico/Científico/I+D | 01/01/2009 |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Director Técnico/Científico/I+D | 01/01/2006 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2006 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 01/01/2004 |
| INTERMUNE INC | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
ScripsAmerica, Inc.
 ScripsAmerica, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Hahnemann University
 Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paradigm Biopharmaceuticals Ltd.
 Paradigm Biopharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Engages in repurposing the drug, pentosan polysulphate sodium for the treatment of bone marrow edema | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
